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Abstract: Most knowledge of spider venom concerns neurotoxins acting on ion channels, whereas
proteins and their significance for the envenomation process are neglected. The here presented
comprehensive analysis of the venom gland transcriptome and proteome of Cupiennius salei
focusses on proteins and cysteine-containing peptides and offers new insight into the structure
and function of spider venom, here described as the dual prey-inactivation strategy. After venom
injection, many enzymes and proteins, dominated by α-amylase, angiotensin-converting enzyme,
and cysteine-rich secretory proteins, interact with main metabolic pathways, leading to a major
disturbance of the cellular homeostasis. Hyaluronidase and cytolytic peptides destroy tissue and
membranes, thus supporting the spread of other venom compounds. We detected 81 transcripts of
neurotoxins from 13 peptide families, whereof two families comprise 93.7% of all cysteine-containing
peptides. This raises the question of the importance of the other low-expressed peptide families.
The identification of a venom gland-specific defensin-like peptide and an aga-toxin-like peptide in
the hemocytes offers an important clue on the recruitment and neofunctionalization of body proteins
and peptides as the origin of toxins.
Keywords: in depth transcriptomics; proteomics; venom; enzymes; neurotoxins; α-amylase
Key Contribution: The most detailed analysis of proteins and neurotoxic peptides of a spider venom
identifies α-amylase as a new venom key protein and provides an holistic view on the interaction of
spider venom components with the main metabolic and regulatory pathways of the prey.
1. Introduction
With more than 47,700 species [1], spiders are the most species-rich terrestrial invertebrate group
after insects. They occur in all ecosystems, often in high densities. As general or specialized predators,
spiders primarily prey on arthropods, thus contributing to the important regulation of other species,
e.g., pest insects in agroecosystems [2]. Spider venoms provide a huge variety of venomous compounds
to subdue their prey and to defend against aggressors [3], thus representing an important source for
the development of human therapeutics and pest control [4,5]. In the last few years, the appearance
of affordable transcriptome analyses and mass spectrometric proteome analyses [6–8] dramatically
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accelerated venom research, which has, for many years, mainly been based on the identification and
isolation of single venom components. Thereby, most publications mainly investigated only small
organic compounds, neurotoxins, and their interaction with a variety of ion channels and other targets.
Other venom components, such as cytolytic peptides or proteins [3] were either only reported to occur
in few spider venoms or have, with a few exceptions, not been as deeply investigated.
The role of enzymes in spider venom was controversially discussed, and only recently hyaluronidase
was found to have an important role in supporting the venomous effect in most spider families [9].
Another enzyme, phospholipase D, has been well investigated due to its severe effects on humans.
The presence of this cell-membrane destroying enzyme, however, is restricted to species of the sicariid
family [10]. Modern transcriptomic and proteomic techniques allow the efficient analysis of all amino
acid-based venom components. Analyses of the majority of spider venom transcriptomes are focused
on cysteine-containing, putatively neurotoxic-acting peptides [7,8] and they rarely cover proteins and
enzymes [11].
In this study, we analyze the venom gland transcriptome and proteome of Cupiennius salei [12,13],
one of the best-investigated spider species [14]. With a holistic view on the transcriptomic data and
our long-term experience in venom research, we searched for peptides and proteins influencing the
homeostasis of the prey and/or aggressor, as well as for recruited compounds so far not identified
in the venom gland. We provide evidence that the venom of C. salei interacts with many regulatory
and metabolic pathways, types of tissue, and specific receptors. This disturbs the homeostasis of the
targeted organism in many ways, usually leading to its death or to non-lethal effects. The present
in-depth analysis provides a new understanding of spider venom functionality, presented here as the
dual prey-inactivation strategy.
2. Results and Discussion
2.1. Overview of Venom Gland Composition
The annotation of the C. salei venom gland transcriptome by 454-sequencing resulted in
34,107 contigs as described earlier [15]. In-depth transcriptomic data analysis is supported by top-down
and bottom-up proteomics of venom and by data from previous work [12]. Of all contigs, 38.2% refer
to venom gland-specific peptides and proteins, an additional 39.4% were identified as annotated
sequences, and 22.4% could not be annotated. However, summing up normalized read counts per
contig (TPM) showed that 53% of all expressed sequences belong to venom gland-specific peptides and
proteins, an additional 35% to annotated sequences, and only 12% to unknown sequences. All venom
gland-specific peptides and proteins were manually annotated and divided into three functional
groups: proteins (14%), cysteine-containing (putative) neurotoxic peptides (15%), and short cationic
peptides (24%, not further analyzed here) (Figure 1).
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Figure 1. Functional profile of venom gland-specific transcripts of proteins and (putative) neurotoxins 
of C. salei. Contigs were blasted against UniProt KB (E = 10−5) and searched against Pfam-A.hmm [16]. 
The relative abundancy of functional groups is given in % of normalized read counts per contig 
(TPM), and specified for proteins (green) and cysteine-containing (putative) neurotoxins (orange). 
Proteins and neurotoxin-like structures are annotated based on their similarity to known proteins or 
structural motifs (α-helical motif, inhibitor cystine knot motif (ICK), and colipase MIT1-like fold). 
2.2. Most Abundant Proteins in the Venom Gland Transcriptome and in the Venom of C. salei 
Venom gland proteins were grouped into three functional categories: (1) proteins involved in 
the protein and peptide-processing machinery, (2) proteins possibly recruited and neofunctionalized 
in the venom gland, and (3) proteins with putative functions in the innate immune system of the 
spider. Eighteen out of nineteen identified protein groups exhibit a signal peptide showing that these 
proteins are synthesized in the endoplasmic reticulum (ER), and may act as enzymes within the ER 
or are synthesized for the excretion process in the venom gland [17]. Five of these proteins are 
enzymes, belonging to the protein-/peptide-processing machinery. These are a signal peptidase (SP), 
specific serine proteases (VSP), protein disulfide isomerases (PDI), carboxypeptidase (CPA), and 
peptidylglycine α-amidating monooxygenase (PAM), together representing 30.0% of all expressed 
venom gland-specific protein transcripts (Figure 1). Several protein groups are thought to be 
recruited and neofunctionalized: amylases (α-AMY, 40.9%), cysteine-rich secretory proteins (CRISPs, 
15.7%), angiotensin-converting enzyme (ACE, 3.4%), hyaluronidase (HYAL, 2.2%), cystatin (CST, 
0.4%), thyroglobulin type-1-like protein (TT1LP, 0.3%), insulin-like growth factor-binding protein-
related protein 1 (IGFBP-rP1, 0.1%) [18], Kunitz domain-containing protein (KCP, 0.06%), and 
phospholipase (PLA2, 0.04%). Immune-relevant proteins might be tachylectin 5A (TL5A, 1.2%), and 
leucine-rich repeat protein (5.7%) (Table 1).
Figure 1. Functional profile of venom gland-specific transcripts of proteins and (putative) neurotoxins
of C. salei. Contigs were blasted against UniProt KB (E = 10−5) and searched against Pfam-A.hmm [16].
The relative abundancy of functional groups is given in % of normalized read counts per contig (TPM),
and specified for proteins (green) and cysteine-containing (putative) neurotoxins (orange). Proteins
and neurotoxin-like structures are annotated based on their similarity to known proteins or structural
motifs (α-helical motif, inhibitor cystine knot motif (ICK), and colipase MIT1-like fold).
2.2. Most Abundant Proteins in the Venom Gland Transcriptome and in the Venom of C. salei
Venom gland proteins were grouped into three functional categories: (1) proteins involved in
the protein and peptide-processing machinery, (2) proteins possibly recruited and neofunctionalized
in the venom gland, and (3) proteins with putative functions in the innate immune system of the
spider. Eighteen out of nineteen identified protein groups exhibit a signal peptide showing that
these proteins are synthesized in the endoplasmic reticulum (ER), and may act as enzymes within
the ER or are synthesized for the excretion process in the venom gland [17]. Five of these proteins
are enzymes, belonging to the protein-/peptide-processing machinery. These are a signal peptidase
(SP), specific serine proteases (VSP), protein disulfide isomerases (PDI), carboxypeptidase (CPA), and
peptidylglycine α-amidating monooxygenase (PAM), together representing 30.0% of all expressed
venom gland-specific protein transcripts (Figure 1). Several protein groups are thought to be recruited
and neofunctionalized: amylases (α-AMY, 40.9%), cysteine-rich secretory proteins (CRISPs, 15.7%),
angiotensin-converting enzyme (ACE, 3.4%), hyaluronidase (HYAL, 2.2%), cystatin (CST, 0.4%),
thyroglobulin type-1-like protein (TT1LP, 0.3%), insulin-like growth factor-binding protein-related
protein 1 (IGFBP-rP1, 0.1%) [18], Kunitz domain-containing protein (KCP, 0.06%), and phospholipase
(PLA2, 0.04%). Immune-relevant proteins might be tachylectin 5A (TL5A, 1.2%), and leucine-rich
repeat protein (5.7%) (Table 1).
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Table 1. Overview of the main identified proteins in the venom glands of C. salei.
Protein TPM Transcripts/Precursors (n)/(n)
Length Signal
Peptide (aa)
Length Mature
Protein (aa)
Molecular Mass *
(kDa) (pI) **
InterProScan ID
Predicted Functional Role
Proteomic Coverage [%]
[Trypsin/Chymo-trypsin]
Signal peptidase catalytic
subunit (SPase) 7.97 1/1 177 20.0 (9.21)
IPR001733 Specific
peptidase activity [-/-]
Protein disulfide
isomerase (PDI) 14,970.57 3/2 16 479
54.2 (4.77)
54.1 (4.81)
IPR005792
PDI family
Isomerase activity
[81.6/60.2]
[80.8/56.0]
Venom serine protease
PQM protease
(VSP1_a)
A0A2I5YNR5
A0A2I5YNR1
10,970.57 3/2 18 260 28.0 (7.03)28.0 (7.66)
IPR001314
IPR001254
PQM serine protease
[91.1/81.8]
[91.1/91.1]
Venom serine protease
1_b1/b2
PQM protease (VSP1_b)
12,251.37 2/2 18 261 28.3 (5.84)28.3 (6.12)
IPR001314
IPR001254
Serine protease
[86.8/84.3]
[86.8/77.9]
Venom serine protease 2
(VSP2) 3476.51 3/1 16 281 31.0 (8.03)
IPR001314
IPR001254
Serine protease
[85.2/71.0]
Carboxypeptidase A-like
protein (CPA) 72.70 2/1 18 454 53.1 (6.55)
IPR000834
IPR008969
Carboxypeptidase A
[89.4/66.1]
Peptidylglycine
alpha-amidating
monooxygenase (PAM)
153.60 1/1 25 328 36.9 (5.13)
IPR000720
C-terminal amidating
activity
[82.4/79.9]
α-amylase (α-AMY) 57,070.97 >1 21 510 57.6 (6.61) IPR006046)Alpha amylase [92.2/89.3]
Cysteine-rich secretory
protein
(CRISP1)
19,808.52 2/2 26 418 46.6 (7.54)46.5 (7.54)
IPR001283
IPR002413
CAP domain IPR014044
[94.1/93.2]
[94.1/93.2]
Cysteine-rich secretory
protein (CRISP2) 2121.07 1/1 19 396 44.0 (5.93)
IPR001283
IPR002413
CAP domain IPR014044
[90.8/82.2]
Angiotensin-converting
enzyme
(ACE)
4795.97 4/4 20 614 70.9 (5.82)
IPR033591
Metallocarboxy-peptidase
activity
[91.3/86.8]
[91.3/86.8]
[91.3/86.8]
[91.3/86.8]
Hyaluronidase-like
(HYAL)
tr_A0A0S4JYH2
3040.68 1/1 16 378 43.9 (8.56)
IPR018155
O-glycosyl-hydrolase
activity
[93.7/85.0]
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Table 1. Cont.
Protein TPM Transcripts/Precursors (n)/(n)
Length Signal
Peptide (aa)
Length Mature
Protein (aa)
Molecular Mass *
(kDa) (pI) **
InterProScan ID
Predicted Functional Role
Proteomic Coverage [%]
[Trypsin/Chymo-trypsin]
Phospholipase A2
(PLA2) 60.17 1/1 20 150 16.9 (5.04)
IPR001211
Cell membrane lysis [62.9/47.6]
Cystatin (CST) 559.42 3/2 20 116 13.2 (8.80)13.2 (6.90)
IPR027214
Cysteine-type
endopeptidase inhibitor
activity
[50.7/49.3]
[60.3/49.3]
Kunitz
domain-containing
protein (KCP)
88.19 2/2 16 185 20.6 (4.22)20.5 (4.22)
IPR002223
Serine-type endopeptidase
inhibitor activity
[60.7/44.3]
[60.7/27.9]
TT1LP
Thyroglobulin
type-1-like protein
(TT1LP)
392.26 4/2 18 133 14.9 (4.42)14.9 (4.42) IPR00716
[90.1/84.1]
[88.1/77.5]
Insulin-like growth
factor-binding
protein-related protein 1
(IGFBP-rP1)
G4V4G1
142.67 1/1 17 244 26.7 (5.00)
IPR000867 IGFBP-like
IPR002350 Kazal_dom
IPR007110 Ig-like_domain
[11.9/-]
Tachylectin 5A-like
(TL5A) 1615.50 2/2 18 286
32.4 (5.93)
32.4 (5.93)
IPR002181
Innate immunity
[71.7/53.9]
[71.7/53.9]
Leucine-rich repeat
protein (LRR) 7994.70 2/1 19 297 34.1 (5.29)
IPR032675Leucine-rich
repeat domain; innate
immunity
[83.5/78.2]
Proteins belonging to the neurotoxic protein and peptide machinery are highlighted in dark gray, recruited and neofunctionalized proteins are not highlighted, and possible proteins
belonging to the innate immune system are in light gray. PQM, processing quadruplet motif, * Molecular mass of the mature peptide (Da), ** Isoelectric point (pI). The proteomic coverage
is indicated in % of the full precursor (including signal and pro-peptide, where applicable). Coverage is highlighted in red, if the coverage is not prototypic to the respective protein isoform.
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2.3. Proteins of the Protein- and Peptide-Processing Machinery
2.3.1. Signal Peptidase (SPase)
Removal of the signal peptide of protein and peptide precursors by SPase is the initial step in
the translocation of excretory and secretory proteins across the ER membrane [19]. Although the
identified SPase is a housekeeping enzyme complex, the enzyme is crucial for the processing of venom
gland-specific toxic proteins and peptides. So far, no information is available about protein structure
and subunit composition of arachnid SPase. The catalytic subunit belongs to the serine endoprotease
S26B (S26.023) family (IPR001733). Active site residues Ser 54 and His 94 could be identified when
compared with arthropod peptidase subunit SEC11 (Drosophila melanogaster sp_Q3YMT4) (http://
merops.sanger.ac.uk) [20]. The N-terminal region exhibits a cytoplasmic domain (1–19 aa). The protein
is composed of 177 aa (20 kDa) and shows a high positive charge (pI of 9.21). The C. salei SPase
sequence is highly identical to other known spider SPases (identities > 95.4%). A remarkably high
sequence identity of 91.5% was calculated between the C. salei SPase and the horseshoe crab (Limulus
polyphemus) enzyme, and 78.5% identity is shared with the above-mentioned arthropod peptidase of D.
melanogaster (Table 1, Supplementary Figure S1.1).
2.3.2. Protein Disulfide-Isomerase (PDI)
This enzyme, located in the ER, catalyzes the formation and breakage of disulfide bonds during the
folding of proteins and peptides. The PDI may be involved in the folding of neurotoxin precursors [21]
(Figure 1, Table 1). PDI was identified based on similarities with sequences from L. polyphemus (68.3%
identity) and the mite Tetranychus urticae (70.5% identity). The two mature forms of PDI (PDI_1a/1b and
PDI_2) from C. salei differ by eleven mutations in a restricted area of the C-terminus, resulting in 97.8%
identity between both enzymes. These enzymes (IPR005792) exhibit detailed signature matches as the
thioredoxin-like fold (IPR012336), the thioredoxin domain (IPR013766), and the disulfide isomerase
domain (IPR005788) with the redox-active disulphide region motif “APWCGHCK” in its N-terminal,
as well as in its C-terminal part (amino acid residues: 48–55 and 389–396).
So far, no sequence data for PDI identified from other spider venom gland transcriptomes are
available. In our venom gland transcriptome of Alopecosa marikovskyi [22] we identified a corresponding
sequence with 94.9% identity to PDI_1ab, and in the venom gland of Viridasius fasciatus we found a
protein with an identity of 91.9% toward PDI_2. This points toward a strongly conserved enzyme,
which is most probably essential for the proper folding of cysteine-rich venom peptides (Supplementary
Figure S1.2).
2.3.3. Venom Serine Proteases (VSPs)
Most biologically active spider venom peptides comprise a pro-peptide that is removed during
the maturation process. Different amino acid motifs present at the C-terminal end of the pro-peptide
have been described to serve as protease recognition sites for pro-peptide removal. Among them, the
dibasic motif (KR, RR, KK, or RK) [23], and the processing quadruplet motif (PQM; XXXR, where
at least one X = Glu) are the most common motifs. An additional cleavage motif, the inverted PQM
(iPQM; RXXX, where at least one X = Glu), has been described to occur together with the PQM at the
predicted cleavage sites of heterodimeric neurotoxins and cytolytic peptide precursors [24].
Recently, we purified the venom gland-specific serine protease VSP1 that specifically cleaves
PQMs. According to its target motif, we named this enzyme PQM protease [25]. The active PQM
protease exhibits a heterodimeric structure and is responsible for the specific cleavage of the pro-peptide
to activate mature peptide toxins in the venom. Moreover, this type of protease is involved in the
heterodimerization process of neurotoxins [26] by the cleavage of PQMs and inverted PQMs [12].
Overall, two groups of isoform (VSP1_a1,2 and VSP1_b1,2) have been identified with high-sequence
identities of 98.9% between VSP1_a isoforms, and of 99.6% between VSP1_b isoforms. VSP1_a isoforms
exhibit one silent mutation in the nucleotide sequence (G576T), and three mutations in the amino acid
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sequence (F98Y, I100L, and D176N). Sequence identities between 93.3% and 94.3% were calculated for
VSP1_a and VSP1_b isoforms. VSP1_b isoforms differ from VSP1_a in an additional Asn residue at
position 205, and 16 further non-silent mutations. Besides two silent mutations, the most remarkable
difference between the VSP1_b isoforms is a point mutation resulting in amino acid exchange C219R,
because the mutation affects the disulfide bond C5-C6 [25]. This may influence the three-dimensional
structure and the substrate specificity of the protease. The two VSP1s isoforms mentioned here exhibit
identical signal peptides and light chains, and seem to be a product of gene duplication (Table 1,
Supplementary Figure S1.3). The different isoforms might be an adaptation to variations in the
cleavage motifs of neurotoxins and cytolytic peptide precursors. We identified multiple venom peptide
precursors with predicted cleavage motifs featuring an Arg residue at position P1, but no Glu residue in
position 1, 2, and 3 after/before an Arg residue (Kuhn-Nentwig, unpublished results). These cleavage
motifs are not classical PQM/iPQM and do not follow the Glu to Arg or/and Glu after Arg-processing
rules [24].
Another VSP2 (Table 1, Supplementary Figure S1.4) is less expressed in the venom glands, but
also belongs to the peptidase S1A chymotrypsin family (IPR001314) with the typical serine protease,
trypsin domain (IPR001254, ~aa 43–285). The active site is the typical catalytic triad of His97, Asp144,
and Ser237. Additionally, amino acid residues Asp231, Ser256, and Gly258 are supposed to be involved
in substrate binding. A cleavage site before Val44 is annotated (cd00190 Tryp_SPc). This cleavage site
supports our hypothesis that VSP2 might be activated by cleavage in the N-terminal part, which then
leads to its heterodimeric structure, comparable to VSP1. Here, the hypothesized light chain (aa 17–43)
might also be connected to the heavy chain by a disulfide bridge, as verified for VSP1. For VSP2, we
identified three transcript variants with the following silent mutations: G414A, C543T, A654G, C882T,
and G888A. Alignment of VSP1 and VSP2 resulted in only 29.3% identity. High identities of 56.9%
to 77.6% were found in the MSA of the VSP2 of different spider species (Supplementary Figure S1.4).
The isoelectric point of VSP2 is two units higher than the one of VSP1, which might be indicative of
a different pH optimum of the two enzymes. In contrast to all other venom gland-specific proteins
here described, VSP1 and VSP2 are characterized by a twofold stop signal. VSP1 shows identities of
59%–98% to putative protease homologs from 18 spider species of nine families from the retrolateral
tibial apophysis (RTA) clade, as recently reported [25].
Besides their involvement in the maturation process of venom peptides and proteins, VSPs may
also cleave unknown targets in the prey. However, VSPs are thought to have high substrate specificity,
as protease activity tests with the unspecific protease substrate AzocollTM only showed very low
proteolytic venom activity after 24 h of incubation [27].
2.3.4. Carboxypeptidase A-Like Protein (CPA)
Within the maturation process of precursors, the next step requires a carboxypeptidase for
the removal of the C-terminal Arg in heterodimeric neurotoxins and the C-terminus of cytolytic
peptide precursors [25,26,28]. We identified a peptidase M14, metallo carboxypeptidase A-like protein
(IPR000834) with the typical Zn2+ binding site motif HXXE + H (His68, Glu71, His175), and the
M14_CP_N/E_like active site (cd03858) (Table 1, Supplementary Figure S1.5). This enzyme may be
responsible for removal of C-terminal Arg-residues from immature venom peptides. The enzyme
exhibits high identities towards CPA proteins identified in the venom gland of A. marikovskyi (82.1%),
V. fasciatus (79.0%), and Stegodyphus mimosarum (65.1% genomic DNA).
2.3.5. Peptidylglycine α-Amidating Monooxygenase (PAM)
Besides further post-translational modifications, C-terminal amidation of the short chain of VSP1
as well as of some neurotoxins and cytolytic peptides in the venom of C. salei is the final step in
protein and peptide maturation. PAMs are proteins with two different enzymatic activities. First,
the production of a peptidyl-α-hydroxyglycine intermediate is catalyzed by the peptidylglycine
α-hydroxylating monooxygenase (PHM), followed by the formation of the α-amidated peptide by
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the peptidyl-α-hydroxyglycine α-amidating lyase (PAL) [29]. Transcriptome data analysis revealed
C-terminal Gly-residues as a prerequisite for the amidation of the short chain of VSP1 and diverse
neurotoxins and cytolytic peptides. Amidation of these peptides was confirmed by proteome
analysis [12].
The PAM exhibits the copper type II ascorbate-dependent monooxygenase N-terminal (IPR000323)
and C-terminal (IPR024548) domains with the histidine cluster 2 H-x-F-x(4)-H-T-H-x(2)-G. MSA with
homologs of other spiders shows partially high-sequence identities with the enzyme from A. marikovskyi
(90.9%), V. fasciatus (83.8%), and Parasteatoda tepidariorum (72.7%). Lower identities were obtained with
a scorpion (Tityus obscurus, 64.1%) and a horseshoe crab (L. polyphemus, 61.2%) (Table 1, Supplementary
Figure S1.6).
2.4. Recruited and Neofunctionalized Proteins
Recruitment of genes in the venom glands and neofunctionalization after gene duplication is
thought to be the origin of venomous peptides and proteins in venom glands of not only arthropods
but also other animals. Importantly, these proteins often participate in key regulatory processes in
animals [30–32].
2.4.1. α-Amylase (α-AMY)
α-amylases are widely distributed in bacteria, archaea, fungi, and plants [33,34]. Moreover, many
invertebrates and vertebrates express theses enzymes in their salivary glands and in the digestive
liquid [35,36]. In spiders, α-amylases have been detected in the digestive liquid of C. salei, Eratigena
atrica [37], and Nephilingis cruentata [38]. The enzymes act on the α (1 → 4) glycosidic linkages in
starch and glycogen and belong to Family 13 of the glycosyl hydrolases. To the best of our knowledge,
this is the first time that α-amylase is described as a spider venom gland component. Estimated
from transcript abundance, α-AMY is one of the most abundant protein groups identified in the
transcriptome of C. salei, accounting for 41% of all venom gland-specific proteins (Figure 1, Table 1).
Besides one main sequence encoding the α-AMY precursor, we identified different fragments
with non-silent and silent mutations that may point to different mature isoforms. Two mutations
were detected in the signal peptide (G110V and S12C) and five in the mature protein (P66S, N204I,
I206L, R401K, and A511V). The protein exhibited a high molecular mass of 57 kDa, and the putative
isoforms did not vary in length. Ca2+-binding sites and catalytic amino acid residues are shown in
the supporting material (Supplementary Figure S1.7). Unfortunately, no amino acid sequence data
from the α-AMY from the digestive liquid of C. salei is available but there is a 75.2% identity with the
α-AMY from the digestive liquid of Nephilingis cruentata. Venom α-AMYs are possibly widespread
within araneomorph spiders, e.g., in A. marikovskyi (78.5% identity) and V. fasciatus (88% identity).
Interestingly, we could identify an α-AMY precursor in the venom gland transcriptome of Atypus
piceus (69.1% identity), one the most ancient mygalomorph spiders.
What could be the reason for the neofunctionalization of amylases in spider venom? Glycogen
is identified in arthropods (and most animals) as a carbohydrate storage form [39,40]. In insects,
glycogen is present in the hemolymph, fat body and gut tissue, but also in smaller amounts, in the
muscles [41]. Controlled glycogen degradation in insects is mediated by glycogen phosphorylase.
This enzyme has to be activated by the hypertrehalosemic hormone AKH/HTH, Ca2+, and cAMP,
resulting in the release of glucose-1-phosphate, thus avoiding free glucose [42–44]. Furthermore,
this pathway is coupled with the insulin-signaling system, one of the highest conserved endocrine
systems in invertebrates and vertebrates. In some decapods and arthropods, insulin-like proteins have
been described instead of insulin, where the mature proteins are characterized as two-chain proteins,
comparable to mature insulin [42,45]. Besides glycogen, the main metabolic carbohydrate storage in
insects is the disaccharide trehalose [41]. Glucose is only in the order of 1/100 of trehalose available in
the hemolymph, and it is hypothesized that the nonreducing trehalose is favored over the reducing
glucose, which might prevent undesirable effects in the hemolymph [46]. Injected into an insect,
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α–amylases may release immediately high amounts of glucose from glycogen in the hemolymph and
muscles, which could end in decoupled energy homeostasis, changes in osmotic conditions, and other
symptoms of hyperglycemia with a potentially fatal outcome.
2.4.2. Cysteine–Rich Secretory Proteins (CRISPs)
The second frequently recruited protein group identified in the transcriptome of C. salei consists
of CRISPs (15.7%) belonging to the CAP superfamily (cysteine-rich secretory proteins, antigen 5, and
pathogenesis-related 1 protein), and comprises CRISP1 (14.2%) and CRISP2 (1.5%). We identified three
transcripts of CRISP1, resulting in two protein isoforms. They differ in positions F52Y, A205T, and
S351N. Additionally, three silent mutations were identified in the nucleotide sequences at positions
G45A, A267G, and A161G. An InterPro scan revealed a CAP domain-like structure (IPR014044) in the
N-terminal part of the precursor proteins (aa: 60–222). Furthermore, the following domains, related to
cysteine-rich secretory proteins, were identified: allergen V5/Tpx-like (IPR001283; PR00837), and V5
allergen (IPR002413; PR00838) (aa: 52–68; 112–128; 173–192). Comparable to CRISP1, the precursor
protein of CRISP2 shows the CAP domain-like structure (IPR014044, aa: 56–217), four detailed signature
matches (aa: 89–107; 146–159, 174–190, 204–217) related to allergen V5/Tpx-1(IPR001283; PR00837)
and three signature matches related to V5 allergen (IPR002413; PR00838) (aa: 52–68; 112–128; 173–192)
(Supplementary Figure S1.8). CRISP1 and CRISP2 only share 31.1% sequence identity, possibly
reflecting different protein subfamilies and functions.
The MSA of CRISP1 with CRISPs of other spiders revealed 54.7% identity with venom allergen
5 from Lycosa singoriensis, 51.8% with CRISP1 from V. fasciatus, and 37.4% identity with two further
CRISPs identified in the spider S. mimosarum (Supplementary Figure S1.8). An MSA of CRISP2 and
arthropod venomous CRISPs resulted in identities of 70.1% with the CRISP2 of V. fasciatus, 55.0% with
a CRISP of S. mimosarum, and 44.7% to 46.4% with three mygalomorph spiders: Hadronyche infensa,
Grammostola rosa, and Trittame loki (Supplementary Figure S1.9).
The MSA of CRISP1 and CRISP2 with scorpions T. obscurus, Tityus bahiensis, Lychas buchari, and
Isometroides vescus resulted in identities between 30.7% and 32.6% for CRISP1 and between 39.4% and
41.9% for CRISP2. MSA with ticks showed identities between 27.8% and 29.2% for CRISP1 and between
30.1% and 35.5% for CRISP2. Comparably, lower identities were found between CRISP1 (26.6% to 30.5%)
and CRISP2 (32.4% to 33.3%) with different CRISPs (e.g., venom allergens 5), identified in the venom
glands of stinging insects such as wasps and fire ants (Figure 1, Table 1) (Supplementary Figure S1.10).
In contrast with venom allergen-5, first reported in wasp ([P35786], 23.9 kDa) and fire ant
venoms ([P35778], 26.4 kDa), C. salei CRISP1 and CRISP2 possess a C-terminal extension leading
to molecular masses twice as high. This C-terminal extension of CRISP1 and CRISP2 might be
arachnid-specific as we also identified it in comparable cysteine-rich venom proteins from other
spiders, scorpions, and from the salivary glands of ticks. Due to this important C-terminal difference
between insect and arachnid CRISPs, we generally propose to name such peptides, identified in
arachnid venoms, CRISPs rather than venom allergens. In the venom of cone snails, comparable
cysteine-rich proteins exhibiting the CAP domain were also identified: Tex31 ([Q7YT83], Conus
textile, 31.5 kDa) a calcium-dependent substrate specific protease, MR30 ([A1BQQ5], Conus marmoreus,
30.1 kDa), and GlaCrisp [DQ647193.1]. So far, the substrate-specific proteolytic activity of Tex31 [47]
could not be verified in further studies [48,49]. More recently, functional studies of antigen-5/CAP
family members, identified in the salivary glands of blood-sucking insects, revealed that these proteins
are Cu2+-dependent antioxidant enzymes involved in the removal of radical superoxide and inhibit
platelet aggregation by collagen and neutrophil oxidative burst [50].
2.4.3. Angiotensin-Converting Enzyme (ACE)
ACE-like enzymes are known from the venom gland transcriptome of Phoneutria nigriventer [11]
and of scorpions [51,52], but also from the salivary glands of hematophagous insects [53]. Moreover,
ACE plays a crucial role in the regulation of peptide hormones present in various types of
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insect tissue [54]. We identified at least four ACE isoforms, featuring the following amino acid
polymorphisms: A10T (signal peptide) and L315I (mature protein). ACE belongs to the protein domain
family of peptidyl-dipeptidase A, M2 metalloprotease group (IPR001548). The metal-binding domain
might be formed by the HEXXH +E motif. The ACE identities between different spiders vary between
83.6% (C. salei/A. marikovskyi), 74.6% (V. fasciatus), 63.8% (S. mimosarum) and 64.9% (P. tepidariorum).
Remarkably, an ACE-like peptidase purified from the venom of the T. serrulatus scorpion converted
angiotensin I into angiotensin II. The crude venom of this scorpion hydrolyzed natural substrates such
as angiotensin I, bradykinin, and hemopressin [51]. Insect ACE is likewise able to convert angiotensin I
into angiotensin II, and to remove Phe-Arg from the C-terminus of bradykinin in vitro, both vertebrate
substrates that have not yet been identified in insects.
So far, no information on whether this enzyme is involved into venomous peptide processing
and modification, or if it acts after injecting venom into the prey’s body in a toxic or synergistic
manner, e.g., by destabilization of the target homeostasis through hypertensive effects, is available.
The latter could be mediated by C-terminal hydrolyzation of regulatory peptide hormones in arthropods
(e.g., tachykinin-related insect peptides and, adipokinetic hormone (AKH) peptides) and in small
vertebrates (e.g., angiotensin I, bradykinin, hemopressin) [51,55]. AKH and tachykinin-related insect
hormone families are known to be targets for insect ACE [54]. The MSA of spider venom ACE and scorpion
venom ACE-like peptidases show identities between 55.4% and 59.2% and even more interestingly, 55.5%
identity toward insect ACE (Supplementary Figure S1.11). It is tempting to speculate that spider venom
ACE may act on comparable ACE substrates in prey with dramatic physiological effects.
2.4.4. Hyaluronidase (HYAL)
The structure, N-glycosylation, and function of the hyaluronidase-like enzyme (IPR018155) in
the venom of C. salei have recently been published by our group [9]. Interestingly, most but not all
investigated spider species exhibit enzymatic activity in their venom, which degrades hyaluronan and
chondroitin-4-sulfate in the prey’s tissue, thus acting as a spreading factor for venomous compounds.
HYAL sequences of other RTA clade spiders show identities between 77.3% (V. fasciatus) and 79.9%
(A. marikovskyi) with the C. salei HYAL. Mygalomorph spider HYALs are 49.7% (Brachypelma vagans) to
50.4% (H. infensa) identical (Supplementary Figure S1.12).
2.4.5. Phospholipase A2 (PLA2)
PLA2 activity was identified in the venom of different spider families, such as eresids, miturgids,
lycosids, and hexathelids, indicating a widespread existence of the enzyme [3]. In opposition to
honeybee and scorpion venom phospholipase A2 [56–58], PLA2 sequence data and investigations
concerning its mode of action are very limited for spiders. PLA2 hydrolyzes the sn-2 acyl ester bond of
phospholipids in a Ca2+ -dependent reaction. The hydrolyzation products are lysophospholipids and
free fatty acids. PLA2s may have a heterodimeric structure, as reported for some scorpion PLA2s, in
which a small subunit is linked by a disulfide bridge to the main protein. However, honeybee PLA2 is
composed of two subunits that are not covalently linked [57,58].
PLA2 is much lower expressed in the C. salei venom gland compared to most other venom proteins
(Table 1), which begs the question if it functions as a house-keeping or venomous enzyme. InterPro
sequence classification resulted in the identification of the protein as a member of the phospholipase
A2 family (IPR001211), belonging to the cl05417 superfamily, subfamily cd00125. Honeybee PLA2
belongs to the same superfamily, but to the cd 4704 subfamily. The MSA of C. salei PLA2_CUPSA with
predicted genomic and transcriptomic PLA2 sequences from other spiders shows identities between
88.8% (A. marikovskyi), 63.0% (S. mimosarum), and 58.0% (V. fasciatus). The low identity of 37.4% with P.
tepidariorum points to the problem of differentiating between PLA2 as toxic component in the venom
and PLA2 sequences, which are part of the housekeeping genes. The pro-peptide structure of honeybee
PLA2 and the N-terminal amino acid residues of spider PLA2 feature a possible cleavage site for a
specific protease. Cleavage may result in a heterodimeric structure, comparable to the one of the
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recently published PQM-protease of C. salei (Supplementary Figure S1.13). The biological activities of
venomous PLA2s are mainly known from snake PLA2s, with a broad scale of effects, such as hemolytic,
neurotoxic, cardiotoxic, anti-inflammatory, and myonecrotic, and the blocking of ion channels [58].
2.4.6. Cystatin (CST)
CSTs occur in prokaryotes and eukaryotes [59], and have been identified in the venom glands
of invertebrates and vertebrates [31,60]. Their main function is the partial or total inhibition of
cysteine-type endopeptidases, such as peptidase families C1 (papain family) and C13 (legumain family),
in which CSTs are less selective inhibitors showing low discrimination between endopeptidases and
exopeptidases [61]. C. salei CSTs belong to the cystatin type 2 family (IPR027214) with a cystatin
conserved site (IPR018073). CST_2 exhibits two mutations in the mature protein as R130E and
R132E. Sequence alignments of CST_1,2 with the predicted cystatins identified in A. marikovskyi and
S. mimosarum show identities of 54% and 48.3% with C. salei, and even lower identities (38.2% and
34.3%) with V. fasciatus and P. tepidariorum (Supplementary Figure S1.14). Cystatin may play essential
housekeeping and regulatory roles, and may protect toxic proteins and peptides in the glands from
proteolytic degradation. However, a specific function in the prey’s tissue after injection should not be
excluded. It is reported that hematophagous ticks express cystatins besides other peptidase inhibitors,
in their salivary glands to escape the immune defense of the host organism during blood feeding [62].
2.4.7. Kunitz Domain-Containing Protein (KCP)
KCPs have been identified at a very low expression level (Table 1), and may act as serine protease
inhibitors inside the venom glands. The proteins belong to the pancreatic trypsin inhibitor Kunitz
domain superfamily (IPR036880). Interestingly, two pancreatic trypsin inhibitor Kunitz domains
(IPR002223) are identified within the protein (amino acid residues 28–83 and 111–164, respectively).
The isoforms (KCP_1a and KCP_1b) differ in amino acid residues D107G, K109Q, D112A, and Q116L.
Sequence alignments of different hypothetical spider KCPs with KCP1ab from C. salei show identities
between 50.3% and 69.7% for araneomorph spider proteins (A. marikovskyi, V. fasciatus, S. mimosarum)
and of only 36.3% for the mygalomorph spider T. loki (Supplementary Figure S1.15).
Kunitz-type serine protease inhibitors are widely spread in many types of plant and animals tissue.
Furthermore, similar proteins with inhibitory activity against serine proteases were identified in the venom
glands of insects [63], scorpions [64], pseudoscorpions [65], and spiders [66]. The fact that blood-sucking
arthropods, such as ticks (salivary glands, midgut) [62,67] and black flies (salivary glands) [68], also
possess Kunitz domain-containing proteins suggests a double function of these structures inside the
glands and the targeted organism (prey, aggressor, host). The biological function in the glands might be
regulatory in terms of storage and allocation of premature toxic peptides and proteins. After injection, such
compounds may act as an antifibrinolytic, antielastolytic [66], and antihemostatic factor [69], regulating
clotting and inflammatory responses [68], and inhibiting ion channels [70].
2.4.8. Thyroglobulin Type-1 Domain-Like Protein (TT1LP)
We identified a protein, which exhibits two thyroglobulin type-1 domains (IPR036857). A second
isoform is present with only one mutation (T31M). The identification of these domains points to a
possible role as a protease inhibitor because the thyroglobulin type-1 domains belong to MEROPS
protease inhibitor familyI31 (http://merops.sanger.ac.uk). MSA with other spiders shows an identity
of 76.8% with a protein from V. fasciatus and of 49.7% with a protein from the mygalomorph spider
Haplopelma schmidti (tr_B5M6G6). Lower identities of 28.5% and 33.3% were obtained by MSA with
the ctenid P. nigriventer and the theridiid Latrodectus hesperus (Supplementary Figure S1.16). TT1LPs
have been detected in the venom and salivary gland transcriptomes of arachnids, and seem to be
a fixed constituent of the venomous cocktail of spiders, scorpions [71], pseudoscorpions [65], and
blood-sucking ticks [72]. Proteins, exhibiting the thyroglobulin type-1 domain, may act as specific
cysteine protease inhibitors [73] within the venom glands and/or in the prey.
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2.4.9. Insulin-Like Growth Factor-Binding Protein-Related Protein 1 (IGFBP-rP1)
IGFBP-rP1 was previously identified in the venom glands of C. salei [18]. This protein is
characterized by four overlapping domains. An N-terminal highly structured globular insulin-like
growth factor-binding domain (IPR000867) is followed by a Kazal-domain (IPR002350), acting as linker to
the two C-terminal immunoglobulin-like/immunoglobulin subtype domains (IRP007110/IPR003599).
High sequence identities of 72%–92% were observed between different spider IGFBPrPs, ticks (62%),
and the spiny lobster, Sagmariasus verreauxi, a decapod crustacean (39%) (Supplementary Figure S1.17).
Decapod IGFBP-related proteins are involved in the insulin-signaling pathway and are able to bind
insulin like peptides (ILPs) [74]. In parasitic ticks, similar proteins are involved in their blood feeding
activity [75]. It is tempting to speculate that, besides α-AMY, IGFBP-rP1 is another protein that interacts
with the insulin-signaling pathway with undesired effects for the bitten prey or aggressor.
2.5. Proteins Belonging to the Innate Immune System
2.5.1. Tachylectin 5A-Like Protein (TL5A)
Two TL5A-like proteins from the venom gland of C. salei exhibit the fibrinogen, α/β/γ chain,
C-terminal globular domain (IPR002181). Two mutations occur at positions T61A and D193N.
Additionally, a silent mutation was identified at position T579C. Tachylectin-5A, a lectin, was first
described as a component of the innate immune system of the horseshoe crab Tachypleus tridentatus
(Q9U8W8) that agglutinates a great variety of acetyl group-containing molecules and therefore plays
an important role as first-line defense against microbes [76,77]. TL5A may acts as a first defense against
microbial infections of the venom gland or it may be active in venom gland homeostasis. TL5A-like
proteins were identified in the venom glands of theridiids (51.6% identity), eresids (59.7%), ctenids
(67.8%), and lycosids (62.3%) (Supplementary Figure S1.18), but also in the hemocytes of C. salei
(unpublished results L. Kuhn-Nentwig).
2.5.2. Leucine-Rich Repeat Domain-Containing Protein (LRR)
We identified a protein, classified by InterPro as a possible member of the leucine-rich repeat
domain superfamily (IPR032675), which exhibits five typical subtype LRR_typ_2 motifs of 20–23 amino
acids. This protein was also identified in the transcriptomes of other spiders, and shows identities
between 70.8% and 85.9% with V. fasciatus, Oxyopes lineatus and A. marikovskyi and of 68% with
S. mimosarum LRRs. Leucine-rich repeats are known to often be involved in protein-protein interactions.
Some ticks are well known to be infected with parasites and, subsequently, for transmitting parasites
into the hosts. It could be shown that LRR domain-containing proteins were upregulated in the salivary
gland and midgut of the infected tick Haemaphysalis longicornis during blood feeding. It is stated that
LRRs play a key role in the tick innate immunity in controlling Babesia parasites [78]. Analogous to
this, a possible function of LRRs in venom glands could be protection against undesired microbes that
might invade spiders after injecting venom into an organism (Supplementary Figure S1.19).
2.6. Cysteine-Containing (Putative) Neurotoxins
To obtain comparable expression data of different neurotoxins, besides real-time PCR, two
possibilities exist. (A) Normalizing and counting sequencing reads that map to contigs of a given
neurotoxin, or (B) counting only reads that map to the mature peptide sequences within the contigs. For a
given contig, we often observed a great imbalance of the number of normalized reads mapping to signal,
pro-peptide or mature peptides. For quantification, therefore, we only considered reads mapping to
the full mature peptide sequences of contigs (n(full reads) = 2420) related to venom neurotoxins. For two
peptides (CsTx-39 and CsTx-20a, b), and 13 further isoforms of different peptides, no full reads were
available, and therefore overlapping reads (n(no full reads) = 15) were used and counted each as one read.
Identified (putative) neurotoxins were classified into peptide families based on an updated version
of HMMs [79]. Peptides were named according to the present valid nomenclature for spider peptide
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toxins [80]. Most of the toxins exhibit the inhibitor cystine knot (ICK) fold [81], the second most
abundant fold is the colipase MIT1-like fold [82]. Two sequences show unknown cystine-folding
patterns (Table 2). For a venom gland-specific defensin, the conserved cystine-stabilized α/β structural
fold is supposed [83].
Table 2. Overview of the 56 identified (putative) neurotoxins und their cysteine framework in the
venom glands of C. salei.
SN_Peptide
Family_Group
Cupiennius salei
Neurotoxin
Arachnoserver
Nomenclature Mature Toxins N Cysteine Framework
Neurotoxins exhibiting N-terminal ICK fold and C-terminal α-helix
SN_19_13
SN_19_14
SN_19_12
CsTx-1a,b,c
CsTx-10a,b
CsTx-11a,b
CsTx-13a,b
CsTx-12a,b
CsTx-8a,b
Omega-ctenitoxin-Cs1a„c
U5-ctenitoxin-Cs1a,b
U6-ctenitoxin-Cs1a,b
U2-ctenitoxin-Cs1a,b
U3-ctenitoxin-Cs1a,b
U4-ctenitoxin-Cs1a,b
2 [1]
2 [2]
2 * [1]
1 [1]
2 [2]
1 [1]
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Colipase MIT1-like fold  
Neurotoxins exhibiting ICK fold
SN_19_13 CsTx-9a,b,cCsTx-33a,b
U1-ctenitoxin-Cs1a,b,c
U7-ctenitoxin-Cs1a,b
2 [2]
1 [1] C8C1C13C1C#
SN_19_06 CsTx-23a,b U8-ctenitoxin-Cs1a,b 2 [2] #C6C6CC4C1C13C1C#
SN_02_03
CsTx-17
CsTx-31a,b,c,d
CsTx-25
CsTx-28a,b
U9-ctenitoxin-Cs1
U10-ctenitoxin-Cs1a,b,c,d
U11-ctenitoxin-Cs1
U12-ctenitoxin-Cs1a,b
1 [1]
3 [2]
1 [1]
2 [2]
#C6C6CC4C1C6C1C#
SN_02_04 CsTx-36a,b,c U13-ctenitoxin-Cs1a,b,c 1 [1] # 6 4 C4C1C6C1C#
SN_02_07 CsTx-18a,bCsTx-19
U15-ctenitoxin-Cs1a,b
U16-ctenitoxin-Cs1
2 * [1]
1 [1] #C4C6CC4C1C4C1C#
SN_02_16 CsTx-34a,b U14-ctenitoxin-Cs1a,b 1 [1] # 6 6 C4C1C10 1C#
SN_33_00 CsTx-26 U17-ctenitoxin-Cs1 1 [1] 4 C4C1C6 1C#
SN_29_01 CsTx-30 U18-ctenitoxin-Cs1 1 [1] #C6C6CC4C1C15C1C#
SN_34_00 CsTx-29 U19-ctenitoxin-Cs1 1 [1]
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U23-ctenitoxin-Cs1
U24-ctenitoxin-Cs1a,b,c
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SN_31_04 CsTx-24a,b,c
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U25-ctenitoxin-Cs1a,b,c
U26-ctenitoxin-Cs1
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Unknown cystine fold
SN_44_00 CsTx-27 U27-ctenitoxin-Cs1 1 [1] # 6C1C10C1C13C#
SN_42_00 CsTx-40 U28-ctenitoxin-Cs1 1 [1] # 6C1C10C1C7 5C19C
Colipase MIT1-like fold
SN_20_01 CsTx-20a,b U29-ctenitoxin-Cs1a,b 2 [2]
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To our astonishment, 93.7% of all expressed neurotoxin-like transcripts are classified in only two
different peptide families. These are the SN_19 family (83.1%), with subgroups SN_19_06, 12, 13 and 14,
and the SN_02 family (10.6%) with subgroups SN_02_03, 04, 07 and 16. In contrast, the lower-expressed
(putative) neurotoxins (6.3%) belong to 13 different peptide families and several subgroups (Figure 2).
The transcripts of these peptides are all composed of a signal peptide, a pro-peptide with a C-terminal
processing motif (PQM, in rare cases a dibasic “KR” motif), and the mature peptide. Some mature
peptides feature a C-terminal glycine residue for PAM-mediated amidation [24] (Supplementary
Table S1). Astonishingly, transcripts that belong to the SN_02 family were likewise identified in
the transcriptome of the pseudoscorpion Synsphyronus apimelus [65]. The majority of C. salei’s
(putative) neurotoxins exhibit similarities to neurotoxins of other araneomorph spiders, but not
mygalomorph spiders. The only toxin family found in C. salei and in mygalomorph spiders, scorpions,
and pseudoscorpions is the SN_32 family (MIT1-like AcTx family) [86]. Besides the SN_32 family,
transcripts of the related SN_20 family were identified in C. salei and other araneomorph spiders.
Peptides of these families are composed of a signal peptide, directly followed by the mature peptide
and a stop signal. Although nothing is known about the target of these peptides, they might represent,
besides enzymes and protease inhibitors, one of the phylogenetically first peptides recruited into
spider venom glands.
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Figure 2. Classification and characterization of high- and low-expressed (putative) neurotoxins
identified in the transcriptome of C. salei. Toxin names, following the CsTx numbering system, are
indicated by numbers in the slices and slice size represents the expression level as estimated by full
read counts of relevant contigs. Structural motifs (detailed in the figure legend) and family annotations
of toxins according to reference [79] are detailed in black and colored lines on the outer side of the
respective slices.
In total, we identified 81 transcripts of (putative) neurotoxins resulting in 66 different precursors
and 54 mature variants. The majority of the mature peptide variants were confirmed by sequence
analysis via Edman sequencing and/or top-down/bottom-up proteomics. Two further peptides, which
we have not identified in the transcriptome, have been formerly determined by Edman degradation
(CsTx-11b and CsTx-18b); thus, the total number of neurotoxins is 56.
2.7. Signal Peptides and Pro-peptides of (Putative) Neurotoxins
The lengths of the signal peptides of the precursors described here vary only between 16 and
22 amino acid residues, and are independent from the lengths of pro-peptides and mature peptides.
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The pro-peptide lengths vary between 6 and 29 amino acid residues and, for 2/3 of all pro-peptides,
a partial α-helical secondary structure is predicted. We found no length relationship between the
proposed α-helices of the pro-peptides and C-terminal α-helices of mature peptides. However, longer
mature peptides possess longer pro-peptides. In general, pro-peptides exhibit negative net charges,
reaching from −2 to −11. The charge increases with the length of the pro-peptide. These highly
negatively charged pro-peptides might influence folding, processing, and/or storage of the precursors
(Supplementary Table S1). Further investigations, including more neurotoxin precursors from different
spider species, are necessary to shed light on these structures.
2.8. C-terminal Modifications of Mature (Putative) Neurotoxins
C-terminal amidation of mature (putative) neurotoxins occur in the SN_19, SN_02, SN_04, and
SN_05 families. However, in the SN_19 and SN_02 families, we also identified peptides with free
C-termini. Only 30% of all transcripts code for peptides featuring a C-terminal Gly residue before the
STOP codon. So far, C-terminal amidation is thought to influence the biological activity of mature
peptides [87]. We have identified a further C-terminal post-translational modification of neurotoxins
in the proteolytic elimination of C-terminal Arg by an unknown carboxypeptidase. This elimination
was observed for the C-terminal Arg of the α-chain of CsTx-8, 12, and 13 [25], and for the C-terminal
Arg of the monomer CsTx-27. Furthermore, the proteomic data provides evidence for removal of the
C-terminal Lys from monomers CsTx-41 and 42 (Supplementary Table S1).
2.9. SN_19 Family
The SN_19 family is the most abundant peptide family (83.6%) identified in the venom and
venom gland transcriptome of C. salei [12]. This family combines neurotoxins of different structural
motifs (Table 2, Figure 3). The main neurotoxin CsTx-1 (26.4%), is characterized by an N-terminal
ICK motif and a C-terminal α-helix. This α-helical part acts in a cytolytic manner [15], whereas the
N-terminally located ICK-fold seems to be responsible for the inhibition of L-type Ca2+ channels [88].
The presence of two different motifs within CsTx-1 enhances insecticidal activity when compared with
the C-terminally truncated form [27]. Such a motif combination is also present in CsTx-10a, b, and 11a,
b (1.7%) with a shorter C-terminal α-helical part. No C-terminal α-helix, but an ICK motif is predicted
for CsTx-9a, b, c (6.7%), as well as for CsTx-33a,b (0.4%).
CsTx-1 exhibits identities between 39.4% and 52.3% with peptides from two distant spider
species within the RTA clade: V. fasciatus (VIRFA_DN65866_c0_g1_i1_4) and L. singoriensis (B6DCP0).
A comparable peptide is identified in Nephila pilipes (NEPPI_DN30656_c0_g6_i1_5, 42.9%), belonging to
the Araneoidea. All these related peptides are composed of two structural motifs, an N-terminal ICK
motif and a C-terminal α-helix. Of interest is the high identity of CsTx-1 with the C-terminal domain of
δ-miturgitoxin-Cp2a (A0A059T2H4, 44.6%) from Cheiracanthium punctorium, which exhibits N-terminally
the ICK motif and C-terminally a short α-helical structure. So far, three different peptide groups have been
mainly described from the venom of C. punctorium and all belong to the SN_19 family [89]. These peptides,
in which two neurotoxins succeed each other, might be interpreted as a specific further development
of the SN_19 toxin family. The N-terminal domain is characterized by an ICK motif followed by a
short-extended strand, randomly coiled, or an α-helical region that connects to the C-terminal domain.
This domain is again characterized first by an ICK motif, followed by differently pronounced α-helical
tails comparable to CsTx-1, 10, and 11 (Supplementary Figure S2.1/S2.2).
Up to now, CsTx-1 has been the only known neurotoxin that exhibits such a long cationic
C-terminal tail of 30 amino acid residues, and therein an α-helical region composed of 14 amino acid
residues. However, L. singoriensis expresses several two-motif neurotoxins in which the C-terminal
tail is composed of 21 and 28 amino acid residues with an α-helix buildup of six to 12 amino acid
residues [90]. It is supposed that such C-terminal structures are acting as possible anchors, attracting
negatively charged lipid rafts or glycoproteins on different membrane types [15,91]. Dependent on the
length and charge of their C-terminal α-helices, the neurotoxic activity of such peptides is enhanced by
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the cytolytic activity towards different cell types. Missing a specific target (e.g., specific ion channels),
the cytolytic-acting C-terminus can still harm a prey [92].
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The highest-expressed mature peptides belong to the two-chain peptides CsTx-8, 12, and 13 (48.3%)
that exhibit, besides the N-terminal ICK motif, a C-terminal α-helical motif of 11 amino acid residues [26].
The main difference to other peptides from the SN_19 family is a specific post-translational modification.
Here, the PQM-protease, which is typically responsible for cutting pro-peptides from mature peptides,
recognizes a PQM, as well as an inverted PQM within the mature peptide chain. As a result, the loop,
defined by the disulfide bridge between C6 and C7, is opened by cutting out a six amino acid polypeptide
and two short peptide chains remain [25]. These heterodimeric peptides are alone less insecticidal than the
main toxin CsTx-1, but in combination with other monomeric peptides from the SN_19 family, (e.g., CsTx-9
or CsTx-1), a synergistic increase of toxicity is observed [26]. With this, C. salei exhibits a strategy to
enhance the insecticidal activity of the SN_19 peptide family by a so far unknown peptide-peptide
interaction between two-chain peptides and single-chain peptides [26]. Fro an evolutionary point
of view, it can be assumed that the synergistic action and in this respect, the production of low toxic
he erodimers (e.g., CsTx-13), provide greater benefit than higher production rates of a more toxic mon mer
(e.g., CsTx-1).
In- epth transcript analysis of the SN_19_00 family discloses a recombination and/or splicing
process concerning signal peptides, pro-peptides, and mature peptides between the different genes
of the two-chain peptides CsTx-8, 12, 13, and the single chain peptides 10, 11a, and 9. All these
neurotoxins exhibit the unique sequence “EVQR” as PQM. In multiple cases, heterodimeric toxins
exhibit identical coding sequences for signal and pro-peptide with monomeric toxins. This holds true
for CsTx-13a, b; CsTx-10a, b, and CsTx-11a, CsTx-8a and CsTx-9c, CsTx-12b and CsTx-9a, and CsTx-12a
and CsTx-9b. It is thereby astonishing that some peptides with identical signal and pro-peptides show
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higher sequence differences in their mature chain (e.g., heterodimers CsTx-8 and 9c), than other
peptides with different signal and pro-peptides (e.g., heterodimers CsTx-8, 12, and 13) (Figure 3,
Supplementary Figures S3.1–S3.3).
CsTx-23a,b precursors (0.08%) are characterized by an unusually short pro-peptide part composed
of six amino acid residues including the PQM, followed by mature peptides. Compared to other low
abundant precursors identified in C. salei, these peptides show higher identities with peptides so
far described in sparassids (36.0%–52.0%), lycosids (60.0%–62.0%), and viridasiids (46.0%–48.0%)
(Supplementary Figure S2.3). Interestingly, the length of the pro-peptide for the related precursors
(C. salei and L. singoriensis) is conserved with four or six amino acid residues.
2.10. SN_02 Family
The SN_02 family includes the shortest neurotoxin-like peptides identified in the venom of C. salei.
The (putative) neurotoxins are characterized N-terminally by an ICK motif, a fourth disulfide bridge
(C6–C7), and a C-terminal tail composed of five to 15 amino acid residues. CsTx-19 (8.0%) is the most
abundant peptide of this family. Its signal and pro-peptide sequence exhibits a high identity (94.1%)
with the corresponding sequence of CsTx-18a (1.4%). The mature peptides show a lower identity of
57.1% due to N- and C-terminal elongations of CsTx-18a. So far, similar peptides are not reported
in UniProtKB (BLAST against with an e-value cut off of 10−5), providing evidence that CsTx-18 and
CsTx-19 might represent a specific development within the genus Cupiennius (Figure 4).
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residue differences within the different subgroups are given in red characters, C-terminal amidation is
highlighted in green, and cysteines are highlighted in black. Not sho n are identical a ino acid
sequences ith silent and visible utations ithin the signal and pro-peptide. CsTx-18b* as
sequenced by Ed an degradation [13].
peptide groups of the SN_02 family, which were identifi d n low abund nce in the venom
of C. salei, are widespread among araneomorph spiders, especially within the RTA clade. CsTx-36
(0.37%) and CsTx-28 (0.08%) show identities with peptides from he ctenid P. nigriventer (52.9%) and
the lycosid L. singoriensis (42.6%). For CsTx-17 (1.1%) and CSTx-31 (0.57%), related peptides were
identified in Agelenopsis aperta (identities of 39.5–53.7%) and V. fasciatus (identities of 32.5–42.1%)
(Supplementary Figures S2.4 and S2.5).
A peptide similar to CsTx-34 (0.25%) was identified in P. nigriventer (TX3-5_PHONI) showing
40.5% identity. This peptide inhibits L-type calcium channels [93], produces paralysis in the posterior
limbs and decreases movements after intracerebro-ventricular injection in mice [94]. Moreover, an
identity of 48.8% has been found between CsTx-34 andω-lycotoxin-Gsp2671g from A. marikovskyi [95],
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which modulates P-type voltage-gated calcium channels in vertebrate cerebellar Purkinje cells [96]
(Supplementary Figure S2.6). CsTx-25 (0.08%) shows identities between 47.4% and 53.7%, with
a fragment identified in the transcriptome of V. fasciatus and ω-agatoxin Iva,b, from the agelenid
A. aperta, a P-type calcium channel antagonist of insects and vertebrates [96,97], pointing to a broad
appearance of this peptide type within the RTA clade. The identity towards CsTx-17 is very high
(60.1%) (Supplementary Figure S2.7).
In our in-house hemocyte transcriptome of C. salei, one peptide fragment was identified that
we classified into the SN_02 family. Could this peptide be an evolutionary precursor of the SN_02
family neurotoxins that was recruited into spider venom glands? The agatoxin-like peptide from
hemocytes exhibits 35.9% identity to CsTx-25, but possesses a dibasic KR motif instead of the PQM
as cleavage motif. Surprisingly, the agatoxin-like peptide shows identities between 44.2% and 90.7%
to peptides identified in the genome or in transcriptomes of the honeybee Apis mellifera [98], the
remipede crustacean Xibalbanus tulumensis [99], the tick Ixodes ricinus (A0A147BFN0_IXORI), and the
spider Agelena orientalis [100] (Figure 5, Supplementary Figure S2.7). Recently, the above-mentioned
agatoxin-like peptide from the honeybee was shown to be located in the neuroendocrine tissue
(glandular part of the corpora cardiaca) and might have a function as a neuropeptide and/or ion
channel modulator [98]. It may be possible that this widespread peptide from the neuronal tissue
of several major arthropod groups was convergently recruited into the venom glands of different
venomous arthropods [98].
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Amblyomma triste (tr|A0A023G4R1|), Ixodes ricinus (tr|A0A131YAX3|), Nephila clavipes 
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Figure 5. Sequence relationship of peptides of the S _02 fa ily. Sequence relationship was calculated
using Bayesian inference methods. Sequences derived from veno gland transcriptomes are highlighted
in dark gray, sequences from transcriptomes of other tissues or genomes in light gray. Nodes are
labeled with posterior probability values. The peptide sequences used for analysis are accessible online
with the following sequence identifiers: C. salei HC_agaLP_CUPSA (MH754628), Amblyomma triste
(tr|A0A023G4R1|), Ixodes ricinus (tr|A0A131YAX3|), Nephila clavipes (tr|A0A2P6L7U6|), Xibalbanus
tulumensis (contig00124SPETU, [99]), C. salei CsTx-17 (MH754572), C. salei CsTx-25 (MH754577), C. salei
CsTx-31a (MH754573), Superstitionia donensis (tr|A0A1V1WBV1|), Hadogenes troglodytes (tr|A0A1B3IJ31|),
Viridasius fasciatus (tr|A0A1V0FWF9|), Apis mellifera (XP_003249808).
Recruitment of agatoxin-like tissue peptides occurs not only in the venom glands of spiders, but
also in the venom glands of pseudoscorpions. In such a venom gland transcriptome of Synsphyronus
apimelus, 11 transcripts have been identified that exhibit high identities with precursors from different
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spiders [65]. Based on HMMs [79], we classified ten of these peptides as belonging to the SN_02 family.
The precursors are composed of a signal peptide, a pro-peptide with the dibasic “KR” motif in place of
a PQM as cutting site, and the mature peptide. For such a peptide (Sapi_DN110686_c0_gl_i1), a high
identity of 74.4% was found towards the hemocyte-derived agatoxin-like peptide of C. salei and 38.5%
towards CsTx-25 (Supplementary Figure S2.7).
2.11. Low Abundant (Putative) Neurotoxins
Besides the above-mentioned low abundant (putative) neurotoxins of the SN_02 and SN_19
families, a high variety of low abundant transcripts belong to ten more different peptide families.
Most of them exhibit high identities with neurotoxins or precursors from other araneomorph spiders
in general, or may even be closer related to those from the Araneoidea and/or RTA clade, thus
representing phylogenetically old structures. These “ancient” peptides might not functionally be very
important, but should be seen as a reinsurance to preserve a high combinatorial diversity of active
neurotoxins against a high diversity of targets in different animals.
2.12. SN_04, SN_05, and SN_31 Family
Five different neurotoxin precursor fragments, belonging to the SN_04 family, are present in
concentrations between 0.04% (CsTx-41) and 0.78% (CsTx-42a, b, c) in the venom gland of C. salei.
With seven disulfide bridges, these (putative) neurotoxins exhibit the highest number of cysteines in
venomous peptides so far identified in spider venoms. They show identities between 30.3% and 40.6%
with neurotoxins from ctenids, such as µ-ctenitoxin-Pn1a (P17727|TXL1_PHONI), a state-dependent
inhibitor of neuronal sodium channels [101], and ω-ctenitoxin-Pn3a (P81790|TX34_PHONI) [102,103],
an antagonist of calcium channels (Cav2.1 and Cav2.2). Interestingly, according to UniProtKB
the last two disulfide bridges for omega-ctenitoxin-Pn3a connect C11–C12 and C13–C14 and, for
µ-ctenitoxin-Pn1a, C11–C13 and C12–C14. Identities over 42% were found between CsTx-41 and
CsTx-42a, b, c with putative precursors published for the pisaurid Dolomedes fimbriatus [104] (Figure 6,
Supplementary Figure S2.8).
CsTx-37 (0.08%) was classified into the SN_05 family [79]. The peptide exhibits high identities
with transcripts from pisaurids (67.7%), and sparassids (41.5%). Moreover, CsTx-37 exhibits an identity
of 56.7% with ω-agatoxin-Aa3a from the agelenid A. aperta, which acts as antagonist of synaptosomal
Ca2+ channels [105] (Figure 6, Supplementary Figure S2.9). Besides CsTx-1, we identified another
putative neurotoxin, CsTx-38a, b, c (0.41%), which exhibits a strikingly long C-terminal stretch of
23 amino acid residues mainly composed of five different amino acids: Pro, Leu, Gly, Asn and Arg.
This stretch is at minimum twice as long as the longest C-terminal stretch identified in peptides of
other spider families and might be an innovation of C. salei to enhance toxic activity. Identities of
40.9%–45.5% (ctenids, pisaurids, and oxyopids), and 51.5%–53% (lycosids) were calculated for these
(putative) neurotoxins (Figure 6, Supplementary Figure S2.10).
The SN_31 family includes CsTx-24a, b, c (0.21%) and CsTx-39 (0.04%), which are characterized
by five disulfide bridges. So far, an Interpro scan could not identify any known protein family
memberships for both peptide groups. CsTx-24a, CsTx-24b, CsTx-24c shows high identities with
putative neurotoxins from other spiders, such as pisaurids (68.6%–76.5%), viridasiids (52.0%–54.0%),
lycosids (40.0%–41.2%), and eresids (52.9%–56.9%), one of the oldest araneomorph spider groups after
haplogynes. Therefore, it is tempting to speculate that this family of (putative) neurotoxins could be
widespread at least among entelegyne spiders (Supplementary Figure S2.11).
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2.13. SN_34, SN_29, SN_33, SN_19, and SN_35 Family
The SN_34 family includes peptides that exhibit the ICK motif composed of three disulfide
bridges without a fourth disulfide bridge for C6–C7. CsTx-29 (0.2%) is the only C. salei venom peptide
belonging to this family. The peptide shows identities between 61.8% and 69.4% with peptides of
unknown function from viridasiids and pisaurids (Figure 6, Supplementary Figure S2.12). Peptide
families SN_29, and _33 are characterized by the ICK fold as cysteine framework, and feature a fourth
disulfide bridge between C6 and C7. With CsTx-30 (0.16%), a peptide related to P-type Ca2+ channel
inhibitor ω-Lsp-IA [95], and to a putative neurotoxin from Dolomedes fimbriatus was identified in
C. salei [104] (Supplementary Figure S2.13).
Peptides similar to CsTx-26 (SN_33_00, 0.66%) were identified in many pider families of th
RTA clade (ctenids, lycosids, pisauri s, sparassids) with high sequence identitie of b tween 63.2%
and 82.9%, pointing to a functionally hig ly conserved structure of the m ture peptide. First insights
into spider venom gland transcriptomes of other spider families support the wide distribution of th
conservative peptide family SN_33 (Kuhn-Nentwig and Langenegger, personal communication). Wide
i tribution is further supporte by the high amino acid sequence i ntity of 80% between CsTx-26
a d purotoxin 1 (PT1). PT1, which shows a tin ciceptive activity by the inhibition of P2X3 receptors
of rat dorsal root sensory neurons [106], was first isolated from the lycosid Alopecosa marikovskyi. In
contrast to the conserved sequences of mature peptides, signal pepti e and pro-peptide exhibit lower
sequence identitie , between 33.3% and 64.9%, and might be more spider family-specific (Figure 6,
Supplementary Figure S2.14).
Precu sors of CsTx-33 (SN_19_33, 0.4%) (Supplem nt ry Figure S2.15) and CsTx-35a, (SN_35_00,
0.12%) (Supplementary Table 1, Supplementary Figure S2.16) both exhibit dibasic recognition m tif
“KR”, and only CsTx-33 exhibits an ad itional PQM motif between the end of the signal peptide and
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the first cysteine of the mature peptide. Dibasic motifs have been postulated to serve as pro-peptide
cleavage sites in some neurotoxin precursors of mygalomorph spiders. Some peptides of Trittame loki
(W4VS08) [107] and Haplopelma hainanum (D2Y299) show cleavage motif “KR” [108,109], and some of
Macrothele gigas (P83560) [110] and Atrax robustus (P83580) [111] the cleavage motif “RR”. However,
some toxins also feature a PQM downstream of the dibasic motif (Figure 7A). This presence of multiple
known cleavage motifs at possible pro-peptide cleavage sites shows the importance of proteomic
data for accurate determination of the actual cleavage site. Proteomic top-down analysis revealed
that, in the case of CsTx-33, the PQM motif is used as pro-peptide-cutting site. In contrary, CsTx-35
and some peptides of H. hainanum are cleaved after dibasic motif “KR” (Figure 7A) as shown by
mass-spectrometry and Edman degradation [112], respectively. Further investigations are needed to
explain the observed specificity in pro-peptide cleavage. However, we observed an evident similarity
between the nucleotide sequences of the non-dibasic motif containing CsTx-9, -10, -11, and CsTx-33 in
the region of the pro-peptide-mature peptide junction (Figure 7B), possibly indicating an evolutionary
relationship of these transcript parts. The only mutations within the first 21 N-terminal nucleotides
of the mature peptides of CsTx-33, -10, and -11 are two point-mutations causing the dibasic motif
in CsTx-33.
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Top-down proteomics of CsTx-35 revealed another post-translational modification of the
CsTx-35 precursor. The last twelve C-terminal amino acid residues are post-translationally removed.
This post-translational modification is comparable to the processing of the precursors of CsTx-8, 12, and
13 by the PQM-protease and a so far unknown carboxypeptidase [25] (Figure 6). Remarkably, mature
CsTx-35 showed 92% identity to LDTF-11, a putative neurotoxin from Dolomedes fimbriatus [104],
whereas their signal peptides and pro-peptides showed only 71.4% identity. The mature chains of
CsTx-35 and CsTx-26 are less variable than their signal and pro-peptides when compared with the
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corresponding peptides of other related spiders. These findings are in contrast to the present opinion
that the predominant mutation sites should be in the mature peptides when comparing peptides within
a peptide family of one species. However, Kozlov and coworkers showed, for putative neurotoxin
precursors of D. fimbriatus that the most variable region is the pro-peptide region, followed by the
signal peptide and N-terminal parts of the mature peptides [104].
2.14. SN_42 and SN_44 Family
A high identity of 70.3% was found between CsTx-40 (0.08%) and omega-agatoxin-1A (agelenids),
a heterodimeric neurotoxin and selective L-type calcium channel blocker (Cav/CACNA1) [113,114].
The disulfide bridge pattern for the present 10-Cys-containing peptides has not yet been solved.
Interestingly, this cysteine pattern is widespread within spiders of the RTA clade and can be found in
pisaurids (73.0% identity), viridasiids (76.8%), thomisids (61.1%), and lycosids (80.0%) (Supplementary
Figure S2.17). Comparable to the two-chain neurotoxins CsTx-8, 12, 13 and omega-agatoxin-1A,
CsTx-40 exhibits in its C-terminal sequence an inverted PQM as well as a PQM. The post-translational
modification of this peptide by a PQM protease produces a heterodimeric structure as shown
previously [25]. This also holds true for the related sequences in the above-mentioned spider
families. The resulting long chain, C-terminally comprises 10 amino acids after the last Cys residue.
This C-terminal part is about two times longer than the corresponding sequence lengths of CsTx-8, -12,
and -13. Such long chains might be highly flexible and may interact with other peptides, resulting in
increased toxic activity, comparable to CsTx-8, CsTx-12, and CsTx-13.
CsTx-27 (0.7%) is structurally comparable to CsTx-40 but C-terminally misses two cysteine residues.
Related precursors have been identified only in lycosids (54.0%–58.1% identity). As a result of top-down
proteomics, post-translational modification has been identified for CsTx-27. Here again, the C-terminal
Arg residue is removed by an unknown carboxypeptidase [25] (Supplementary Figure S2.18).
2.15. SN_20 and SN_32 Family
Precursors corresponding to these families are characterized by the missing pro-peptide region,
which seems to be a “requisite” for most so far described (putative) neurotoxins of mygalomorph and
araneomorph spiders [115]. CsTx-20 (SN_20_01, 0.08%), CsTx-21a,b,c,d,e,f,g (SN_32_01, 0.62%), and
CsTx-22a,b,c (SN_32_02, 0.16%) lack these pro-peptides and are present only in low abundances in
the venom. In contrast to (putative) neurotoxins of other peptide families, the mature peptides of the
SN_20 and SN_32 family are more anionic peptides with only net charges between –4 and 1. All these
peptides possess five disulfide bridges (Figure 8).
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family and no domain could be identified. Disulfide bridge connectivity was determined as C1–C4,
C2–C5, C3–C7, C6–C9, and C8–C10 [85], which corresponds to the disulfide pattern of black mamba
intestinal toxin 1 (MIT1) [116]. In contrast to MIT1 (only 23.7% identity), CsTx-20 lacks the N-terminal
AVIT sequence, characteristic for a part of the prokineticin domain that is essential for biological
activity, e.g., pain sensation and stimulation of smooth muscle contraction [86,117]. Blast results show
a broad distribution of CsTx-20 homologs in araneomorph spiders of the RTA clade (pisaurids, 89.5%
identity; sparassids, 67.1%) araneids (67.1%), and eresids, (68.2%), but also in scorpions (Hadrurus
spadix, 31–35.4%). Identifying similar peptides in spider and scorpion venoms points to a common
ancient precursor or a convergent evolution in both arachnid orders. So far, no biological activity is
described for these peptides isolated from spider and scorpion venom (Supplementary Figure S2.19).
Interpro analysis shows that CsTx-22a, b, c comprise the prokineticin domain (IPR023569) nearly
over the whole length of the peptides (amino acid residues 5–59, CsTx-22) but the crucial N-terminal
AVIT sequence part, responsible for its biological activity, is lacking. The prokineticin domain is identified
in several putative toxin precursors from different araneomorph and mygalomorph spiders, but also,
surprisingly, from ticks. Sequence identities between CsTx-22a, b, c and such peptides are medium to high:
for araneomorph spiders 43.9%–7.6%, for mygalomorph spiders 41.8%–49.2%, and for ticks 37.5%–39.1%.
Sequence alignments even show 22.4%–33.4% identity to the prokineticin Bm8f from the toad Bombina
maxima and to MIT1 from the elapid black mamba (Supplementary Figure S2.20).
CsTx-21a, b, c, d, e, f, g are classified as belonging to the atracotoxin family (IPR020202).
This family classification is based on ACTX–Hvf17 [118] and six more MIT1-like ACTX orthologs
isolated from the venom of the mygalomorph funnel web spiders Hadronyche versuta and H. infensa [86].
They share sequence homologies to the above-mentioned MIT1 and Bm8f, but no pharmacological
activity or biological function in the venom is known. Mature CsTx-21 isoforms show amino acid
sequence identities to peptides of other araneomorph spider in the range of 51.6–60.0% and with
mygalomorph spiders in the 38.1%–45.3% range (Supplementary Figure S2.21).
Taking all arguments into account, it is most likely that CsTx-21a, b, c, d, e, f, g, and CsTx-22a,
b, c can be classified as peptides that might exhibit the ancestral disulfide-directed beta-hairpin
(DDH) domain as shown for the nontoxic atracotoxin-Hvf17 (ACTX–Hvf17) identified in the atracid
Hadronyche infensa. The corresponding amino acid consensus sequence is defined as CX5-9CX2[G or
P]X2CX6-19C, which is in accordance with the amino acid consensus sequence CX4-5CX2[G]X2CX8C
of isoforms of CsTx-21 and CsTx-22. Furthermore, loop 3 of this domain is highly conserved as
C–GXGXC–C, comparable to loop 3 of MIT1-like ACTXs [86]. Together with the determined disulfide
bridge pattern of CsTx-20, it seems that CsTx-20, 21, and 22 are the only peptides in the venom of C. salei
that exhibit a DDH fold (Colipase MIT1-like fold), hypothesized to be the evolutionary precursor of
the ICK motif [82]. Identifying related peptides to CsTx-20, 21, and 22, not only in araneomorph and
mygalomorph spider venoms [107], but also in the venom of scorpions [119], pseudoscorpions [65],
and in the salivary glands of ticks [120], may give a clue that these peptides may be one of the
first compounds recruited into venom and salivary glands. Unfortunately, their targets still need to
be elucidated.
2.16. Defensin-Like Peptide
We identified a defensin-like peptide in the venom gland, with a so far unknown function, which
we named defensin-2. Transcripts coding for this peptide have not been identified in our C. salei
hemocyte transcriptome, indicating that defensin-2 is a venom gland-specific peptide. Defensin-2
shows 54% sequence identity to defensin-1, a peptide from C. salei that was shown to be expressed
in ovaries, subesophageal nerve mass, hepatopancreas, hemocytes, and muscle tissue. Neither
reverse-transcriptase-PCR nor 454-sequencing showed any expression in the venom glands of the
spider [121]. Illumina sequencing, however, revealed defensin-1 and defensin-2 homolog transcripts
in the venom glands of Cupiennius getazi, a sister species of C. salei. It is tempting to assume that this
inconsistency is due to the higher read-depth of Illumina sequencing compared to 454-sequencing,
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allowing to detect very low-abundant transcripts that may emerge from a few hemocytes present in
dissected venom glands. The amino acid differences between hemocyte defensins-1 from both sister
species are small (91.9% identity). The same holds true for defensins-2 from venom glands (97.7%)
(Figure 9).
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2.17. Proteomics
We used a combined approach of top-down and bottom-up mass spectrometry to validate the
sequence of venom-neurotoxins and -proteins identified on the transcriptome level. From a total of
54 (putative) neurotoxins and their mature peptide isoforms identified by transcriptome analysis, we
validated the presence of 49 by mass spectrometry of venom fractions (Supplementary Figure S4).
The venom presence of all proteins identified on the transcriptome level, except for the
house keeping protein signal peptidase, could be validated with high sequence coverages (Table 1,
Supplementary Figures S1.1–S1.19). Proteomic analysis is inevitable for identification or validation
of post-translational modifications. Thereby, mass spectrometric analysis of undigested peptides
(top-down proteomics) proved to be highly suitable to identify post-translational processing by
proteases (as discussed to occur in precursors of CsTx-8, -12, -13, -35, and -27) including the allocation
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of the cleaved signal peptide (e.g., for CsTx-22) and pro-peptide-processing motif if multiple motifs
are present (e.g., CsTx-33). However, very low-expressed peptides or large proteins could not be
assessed by top-down proteomics. In such cases, mass spectrometric analysis of digested peptides
(bottom-up proteomics), using multiple proteases for digestion, provided a reasonable alternative
with high sensitivity and sequence coverage (Table 2, Supplementary Table S1). High sensitivity and
sequence coverage are thereby the key to validate low-expressed peptides and highly similar isoforms
of peptides. In addition to mature peptides, we also surprisingly identified fragments of pro-peptides
of some neurotoxins by bottom-up proteomics. It is tempting to assume that these identifications
indicate the presence of immature peptides comprising unprocessed pro- peptides and mature peptides
in the venom or trace amounts of cleaved-off intact pro-peptides. The presence of high quantities
of intact pro-peptides, however, is not likely as pro-peptides of CsTx-1 and CsTx-12 could not be
observed by the anion exchange chromatography of venom (Supplementary Figure S5).
2.18. The Dual Prey-Inactivation Strategy of Spiders
Previously published data on low molecular mass compounds [92,126] and cytolytic peptides
(cupiennins) [127,128], together with the here presented proteins and (putative) neurotoxins open a
holistic view on the synergistic mode of action of C. salei venom compounds after injection into a prey
or aggressor. Analyzing all interacting compounds, we hypothesize a specific and an unspecific prey
inactivation pathway, resulting in a dual prey-inactivation strategy (Figure 10).
Compounds of the specific pathway are neurotoxins, low molecular mass compounds, a highly
active hyaluronidase, phospholipase A2 and the cupiennins. The unspecific pathway includes
α-amylase, CRISPs, angiotensin converting enzyme, cystatin and IGFBP-rP1. In the specific pathway,
a great variety of neurotoxins act synergistically [26], but also with small molecular mass compounds
and cupiennins, all affecting ion channel targets of the nervous system and in muscle tissues,
finally resulting in paralysis, convulsion and death. The spreading of these toxins into the tissue is
supported by hyaluronidase, phospholipase A2 and the cupiennins, through destruction of negatively
charged membrane types. The unspecific inactivation pathway is characterized by different enzymes,
which play a central part by interacting with the regulation of important metabolic pathways,
thus unbalancing the homeostasis of an organism. The main actors are α-amylases, CRISPs, and
angiotensin-converting enzymes. Furthermore, some of the cupiennins inhibit the formation of nitric
oxide by neuronal nitric oxide synthase, which dramatically disturbs numerous processes using
nitric oxide as a neurotransmitter [129]. The dual prey-inactivation strategy of spiders reduces the
development of resistance against single venom compounds and the risk of losing prey due to escape.
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mainly based on neurotoxins and other compounds, usually leads to death. The unspecific or metabolic
pathway, based on a variety of regulatory elements, disturbs homeostasis or leads to hyperglycemia.
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domain-like protein.
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vertebrate aggressors, and (3) proteins of the innate immune system of C. salei, fighting agai st microbial
invaders in t e venom gland and maybe influenci g prey homeostasis. Most of these proteins, identified
on a transcriptomic and proteomic site in C. salei, are also present in the venom glands of other arachnids,
especially in the venom of spi ers, scorpions, a pseudoscorpions, and in the salivary glands of
hematophagous ticks [31,130,131]. This wide distribution y be n example of convergent evolution,
especially when the glands, where these substa ces are expressed, are not omologous.
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In contrast with other spider venoms, the number of different neurotoxin families and neurotoxins
in C. salei is comparatively low. The main actors belong to only two peptide families (SN_19 and SN_02)
that have been highly optimized in terms of synergistic interactions [26]. Eleven further neurotoxin
families are present in the venom in low concentrations; they may belong to a common heritage of
spider toxins, but their evolutionary origin remains unclear.
Our detection of the first spider venom gland-specific defensin and its origin in hemocytes offers
a fascinating possibility to track the origin of toxic compounds, the so-called neofunctionalization,
and provides insight into the process that leads from a nontoxic to a toxic compound. Moreover,
comparable transcriptomic studies of venom glands of different spider families may be a fascinating
approach to filter out the essential constellation of venomous components present in each spider
venom. Such a constellation might yield a principal composition that is not only realized in spider
venoms, but also in the venoms of other arachnids.
4. Materials and Methods
4.1. Spider Maintenance, Venom Collection, and cDNA Libraries
Breeding of Cupiennius salei and venom collection were done as described earlier [132]. The cDNA
libraries of venom glands and hemocytes of C. salei are based on 454-sequencing and were reported
previously [15]. For transcriptomic studies, Ancylometes rufus, Viridasius fasciatus and Cupiennius
getazi were laboratory-bred. Oxyopes heterophthalmus, Oxyopes lineatus, and Cheiracanthium sp. were
collected in France. Nephila pilipes was collected in Taiwan, and Xysticus cristatus and Atypus piceus
in Switzerland. No specific permissions for collecting the spiders were required. Collections were
done on publicly accessible land without any protection status, such as common land. None of the
spiders described here belongs to a protected or endangered species. The cDNA libraries of the
venom glands of Alopecosa marikovskyi, Ancylometes rufus, Cheiracanthium sp., Nephila pilipes, Oxyopes
heterophthalmus, Oxyopes lineatus, Viridasius fasciatus, and Xysticus cristatus, as well as sequencing with
the next-generation sequencing platform of the University of Bern on an Illumina HiSeq3000 were
performed as described by Langenegger et al. [25]. Multiple sequence alignments (MSA) of related
venom proteins and peptides, as well as the calculation of peptide identities, were performed using
ClustalW (https://www.ebi.ac.uk/Tools/msa/clustalo/) and were also partially manually edited.
Structural analysis of the protein domains was performed using InterPro [133], and classification of
the sequences into different families with HMMcompete [79] that had to be enlarged to cover a wider
number of neurotoxins. Information about the secondary structure of the peptides was obtained using
the GOR IV secondary-structure prediction method [134]. Measurement of mRNA abundance in the
transcriptome (contigs) was done as reported in Reference [135] and given as Transcripts Per kilobase
Million (TPM).
4.2. Transcriptome Analysis
The assembled reads were analyzed following the workflow described in Supplementary Figure
S6 using BlastP against UniProtKB (E-threshold, 0.0001; BLOSUM-62, non filtering and gapped;
UniProtKB/Swiss–Prot 2018_06–June 20, 2018), SignalP [136], in-house Hidden Markov Models
(HMMs), cysteine pattern search scripts, Getorf (http://www.bioinformatics.nl/cgi-bin/emboss/
getorf), and Pfam2go. All obtained contigs and the corresponding reads, referring to venom
gland-specific proteins, (putative) neurotoxins, and peptides, were further analyzed on the nucleotide
level to detect transcript isoforms. Nucleotide sequence variants that obviously resulted from
sequencing errors/frame shifts were excluded.
4.3. Tandem Mass Spectrometry
We analyzed the venom proteome of C. salei combining bottom-up and top-down proteomics.
To reduce sample complexity for further LC-MS2 analyses, 50 µL venom was separated into seven
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fractions by size exclusion chromatography on a Superdex 75 Increase HR 10/300 column (GE
Healthcare) using 50 mM NH4OAc pH 5.0 supplemented with 500 mM NaCl as the liquid phase
(Supplementary Figure S7). All fractions were desalted by RP-HPLC and analyzed by bottom-up
proteomics. Peptide-containing fractions (2–7) were additionally analyzed with a top-down proteomic
approach. For bottom-up proteomics, 20 µg protein was reduced and alkylated followed by digestion
with trypsin and chymotrypsin, respectively, as described elsewhere [137]. Further LC-MS2 analysis
was done on an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific) with a Dionex
Ultimate 3000 nano-UPLC system (Thermo Fischer, Bremen, Germany). Protein digests were loaded
onto a pre-column (PepMap C18, 5 µm, 100 Å, 300 µm× 5 mm) at a flow rate of 50 µL/min with loading
solvent (0.05% TFA in water/acetonitrile 98:2). After loading, peptides were eluted in backflush mode
onto the analytical nano-column (C18, 3 µm, 155 Å, 0.075 mm i.d. × 150 mm length, Nikkyo Technos,
Tokyo, Japan) using an acetonitrile gradient of 5% to 40% solvent B (0.1% FA in water/acetonitrile
4.9:95) in 60 min at a flow rate of 400 nL/min. The column effluent was directly coupled with the mass
spectrometer via a nanoflex electrospray source (Thermo Fischer, Bremen, Germany). Precursor ion
scans were recorded in the Fourier transform detector (FT) with a resolution of 120,000 (at m/z = 200),
a maximum injection time (mIT) of 50 ms, and an automatic gain control (AGC) setting of 4 × 105.
High energy collision-activated (HCD) fragment spectra were acquired parallel to the FT scan with a
top-speed fragment spectra acquisition method of the most intense precursor ions in the linear ion
trap for a cycle time of 3 s at an mIT of 35 ms, AGC of 1e4, and exclusion from further fragmentation
for 30 s, using a relative HCD energy of 30%.
For top-down proteomics, 250 ng of reduced and alkylated protein was analyzed on the same
nano-LC-MS2 setup as for bottom-up. Proteins were separated by a two-step acetonitrile gradient rising
from 5% to 20% within 15 min and then to 60% within 30 min. Precursor and fragment spectra were
both recorded in profile mode with the orbitrap detector using a resolution of 120,000 (at m/z = 200).
The MS1 full scan range was 500–2000 m/z, the AGC was at 5 × 105, and the maximum injection time
was 50 ms, using a declustering potential of 15 V at the source. Data-dependent fragment spectra
on the top three most intense precursor ions were produced by electron-transfer dissociation (ETD)
fragmentation using a supplemental relative collisional activation of 15% (EThcD). All charge states
bigger than 6 were included with an isolation width of 3 Da, and no dynamic exclusion was applied
except for isotopes of the same charge state within ±1.5 m/z. ETD reaction time was set to 10 ms
with a target of 7 × 105 anions and a maximum injection time of 200 ms. Fragment spectra were
recorded within 200–2000 m/z, an AGC of 106, and a maximum injection time of 250 ms by combining
5 microscans.
4.4. Tandem Mass Spectrometry Data Analysis
Top-down data were analyzed using the TopPIC suite [138]. First, Thermo RAW files were
converted to centroided mzXML files using MSConvert ([139], version 3.0.11781). The resulting files
were used for deconvolution with TopFD (version 1.1.2) applying the following settings: maximum
charge, 15; maximum monoisotopic mass, 15,000 Da; error tolerance, 0.01 m/z; signal/noise ratio, 1;
precursor window size, 3 m/z. The output files were used for identification of proteoforms with TopPIC
(version 1.1.0) by searching the spectra against a database containing the sequences of all peptides and
proteins identified in the transcriptome of C. salei supplemented with all C. salei venom peptides on
UniprotKB (27 August 2018). We used the program’s default settings with the following exceptions:
error tolerance, 10 ppm; N-terminal form, NONE; fixed modification, carbamidomethylation of
Cys (unimod: 4); and variable modification, oxidation of Met (unimod: 35), and Gly-loss + Amide
(unimod: 822). Protein spectrum matches were filtered applying a false discovery rate (FDR) cut-off
of 1%. Protein match tables and detailed analysis results are available as supporting information
(Supplementary Dataset EV1, Supplementary Dataset EV2).
For analysis of the bottom-up proteomic data, fragment spectra peak list files were generated as
mzXML files with MSConvert (version 3.0.18160) using the vendor centroid option. Interpretation of
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fragment spectra was done with the search engines Comet (version 2018.01 rev. 2) [140], Xtandem
(version Jackhammer TPP (2013.06.15.1)) [141], MSGF+ (version 2018.06.18) [142] and Myrimatch
Bumbershoot (release-3_0) [143] against all protein sequences on Uniprot KB matching the search term
[taxonomy: “Araneae (spiders) [6893]” venom] (version 27 August 2018) supplemented with sequences
of neurotoxins and proteins identified in the transcriptome of C. salei and possible contaminants
(ntot = 3587). The search parameters were: sample enzyme trypsin with semi-tryptic peptides allowed,
and chymotrypsin with semi-chymotryptic peptides allowed, respectively; fixed modification of
carbamidomethylation on Cys (unimod: 4); variable modifications of oxidation on Met (unimod: 35),
Gly-loss + Amide (unimod: 822) and protein N-terminal acetylation (unimod: 1); maximum missed
cleavages of 2; precursor and fragment ion tolerance set to 10 ppm and 0.4 Da, respectively. Statistical
validations of peptide identifications were performed using Peptide Prophet [144] implemented in
TPP version 5.1 [145], and IProphet [146] to combine the results of the four search engines. Hits were
filtered at an FDR of 1% and used for Protein Prophet [147] protein reconstruction. Protein hits were
also filtered at an FDR of 1%. Protein and peptide match tables are available as supporting information
(Supplementary Dataset EV3).
4.5. Sequence Analysis
The Bayesian tree was estimated from a cropped and manually validated amino acid sequence
alignment of C. salei peptides of the SN_02 family and homologues identified by BLASTP. We ran
Mr. Bayes (version 3.2.6) [148] for 5,000,000 generations using the Dayhoff rate matrix and
gamma-distributed across-site rate variations (best substitution model as determined using MEGA
7.0.26 [149]). Trees were sampled every 1000 generations. Other parameters were left at default values.
Sampled model parameters and trees were summarized using a relative burnin of 50%. Calculations
were performed on UBELIX (http://www.id.unibe.ch/hpc), the HPC cluster at the University of Bern.
4.6. Sequence Deposition
The nucleotide sequences referred to in this manuscript were deposited in the GenBank
database under GenBank Accession Numbers MH754547–MH754628, MH766616–MH766649,
and MH795777–MH795789.
4.7. Proteomic Data Deposition
The mass spectrometry proteomics data were deposited to the ProteomeXchange Consortium
via the PRIDE [150] partner repository with the dataset identifier PXD012886 (top-down data) and
PXD012881 (bottom-up data).
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